China CAS NO 92-66-0 Factory

Getting buyer gratification is our company's purpose endlessly. We will make good attempts to produce new and top-quality products, meet up with your specific requirements and provide you with pre-sale, on-sale and after-sale expert services for CAS NO 92-66-0,92-66-0,Sacubitril intermediate,Sacubitril advance intermediate,4-Bromobiphenyl, We never stop improving our technique and high quality to maintain up with the enhancement trend of this industry and fulfill your pleasure effectively. For anyone who is fascinated within our solutions, you should get in touch with us freely.
CAS NO 92-66-0, Our Company has specialist engineers and technical staff to answer your questions about maintenance problems, some common failure. Our product quality assurance, price concessions, any questions about the products, You should feel free to contact us.

Hot Products

  • Dasatinib

    Dasatinib

    Product Name:Dasatinib
    Molecular Formula:C22H26ClN7O2S
    Molecular Weight;488.01
    CAS Registry Number;302962-49-8
  • Potassium phthalimide

    Potassium phthalimide

    Product Name:Potassium phthalimide
    Molecular Formula:C8H4KNO2
    Molecular Weight:185.22
    CAS Registry Number:1074-82-4
  • 6-Bromoquinoline

    6-Bromoquinoline

    Product Name:6-Bromoquinoline
    Molecular Formula:C9H6BrN
    Molecular Weight:208.05
    CAS Registry Number:5332-25-2
  • LEE011

    LEE011

    Product Name:LEE011
    Molecular Formula:C22H29ClN8
    Molecular Weight;440.97
    CAS Registry Number;1256963-02-6
  • Dehydronandrolon

    Dehydronandrolon

    Product Name:Dehydronandrolon
    Molecular Formula:C20H26O3
    Molecular Weight:314.42
    CAS Registry Number;2590-41-2
  • Lercanidipine hydrochloride

    Lercanidipine hydrochloride

    Product Name:Lercanidipine hydrochloride
    Molecular Formula:C36H42ClN3O6
    Molecular Weight;648.19
    CAS Registry Number;132866-11-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept